Sterchele P F, Sun H, Peterson R E, Vanden Heuvel J P
Division of pharmacology and Toxicology, University of Wisconsin School of Pharmacy, Madison 53706, USA.
Arch Biochem Biophys. 1996 Feb 15;326(2):281-9. doi: 10.1006/abbi.1996.0077.
Chemical-induced peroxisome proliferation in rodent liver is postulated to occur via activation of members of the steroid hormone receptor superfamily, the peroxisome proliferation-activated receptors (PPARs). In the present study, the expression of the predominant liver subtype PPAR alpha was examined and compared to that of acyl-CoA oxidase (ACO), a marker for peroxisome proliferation and a prototype for genes regulated via PPARs. Despite the induction of both mRNA species in vivo by the peroxisome proliferator perfluorodecanoic acid (PFDA), dose response and time course indicate PPAR alpha and ACO are not controlled similarly. Messenger RNA levels for ACO increased rapidly in rat liver and declined over the subsequent 7 days following PFDA administration, while PPAR alpha mRNA increased slower and remained elevated over this period. In addition, PPAR alpha mRNA accumulation in PFDA-treated rats appears to be due primarily to hypophagia as pair feeding and complete caloric restriction result in a large increase in the concentration of this messenger RNA. Nuclear run-on experiments in vivo suggest that, unlike ACO, PFDA as well as caloric restriction results in accumulation of PPAR alpha mRNA which cannot be explained solely by transcriptional activation. These data indicated that PPAR alpha mRNA accumulation has a very small peroxisome proliferator-dependent component and that other factors may be involved. A rat hepatoma cell line was examined to determine the direct effect on peroxisome proliferators on PPAR alpha mRNA. PPAR alpha and ACO mRNA levels were increased rapidly in the rat hepatoma cell line FaO after treatment with PFDA or the prototypical peroxisome proliferator Wy 14,643. In this cell line, PPAR alpha mRNA levels are not affected by glucagon or insulin and in addition to peroxisome proliferators are induced in this cell line by oleic acid and dexamethasone. The latter treatment had the greatest effect on PPAR alpha mRNA accumulation while having a minimal effect on ACO mRNA. Treatment of FaO cells with actinomycin D prior to Wy 14,643 abolished ACO and PPAR alpha mRNA accumulation, demonstrating that there must be a transcriptional component of the peroxisome proliferator response. Therefore, although PPAR alpha is responsive to peroxisome proliferators and direct effects are observed in cell cultures, mRNA accumulation in vivo is predominantly posttranscriptional, and endogenous regulators such as glucocorticoids may play critical roles in the tissue- and developmentally specific expression of this steroid hormone receptor.
化学物质诱导的啮齿动物肝脏过氧化物酶体增殖被假定是通过激活类固醇激素受体超家族的成员,即过氧化物酶体增殖激活受体(PPARs)来发生的。在本研究中,检测了肝脏中主要亚型PPARα的表达,并将其与酰基辅酶A氧化酶(ACO)的表达进行了比较,ACO是过氧化物酶体增殖的标志物,也是通过PPARs调控的基因的一个原型。尽管过氧化物酶体增殖剂全氟癸酸(PFDA)在体内诱导了这两种mRNA的产生,但剂量反应和时间进程表明PPARα和ACO的调控方式并不相同。PFDA给药后,大鼠肝脏中ACO的mRNA水平迅速升高,并在随后的7天内下降,而PPARα mRNA升高较慢,并在此期间保持升高。此外,PFDA处理的大鼠中PPARα mRNA的积累似乎主要是由于摄食量减少,因为配对喂养和完全热量限制导致这种信使RNA的浓度大幅增加。体内的核转录实验表明,与ACO不同,PFDA以及热量限制导致PPARα mRNA的积累,这不能仅通过转录激活来解释。这些数据表明,PPARα mRNA的积累只有很小一部分依赖于过氧化物酶体增殖剂,可能涉及其他因素。研究了一种大鼠肝癌细胞系,以确定过氧化物酶体增殖剂对PPARα mRNA的直接影响。用PFDA或典型的过氧化物酶体增殖剂Wy 14,643处理大鼠肝癌细胞系FaO后,PPARα和ACO的mRNA水平迅速升高。在该细胞系中,PPARα mRNA水平不受胰高血糖素或胰岛素的影响,除了过氧化物酶体增殖剂外,油酸和地塞米松也能诱导该细胞系中PPARα mRNA的表达。后一种处理对PPARα mRNA积累的影响最大,而对ACO mRNA的影响最小。在Wy 14,643处理之前用放线菌素D处理FaO细胞,消除了ACO和PPARα mRNA的积累,表明过氧化物酶体增殖剂反应中一定存在转录成分。因此,尽管PPARα对过氧化物酶体增殖剂有反应,并且在细胞培养中观察到了直接影响,但体内mRNA的积累主要是转录后水平的,内源性调节因子如糖皮质激素可能在这种类固醇激素受体的组织和发育特异性表达中起关键作用。